1921
Volume 90, Issue 2
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

There is no abstract available for this article.

[open-access] This is an Open Access article distributed under the terms of the American Society of Tropical Medicine and Hygiene's Re-use License which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Loading

Article metrics loading...

The graphs shown below represent data from March 2017
/content/journals/10.4269/ajtmh.13-0657a
2014-02-05
2020-10-25
Loading full text...

Full text loading...

/deliver/fulltext/14761645/90/2/383.html?itemId=/content/journals/10.4269/ajtmh.13-0657a&mimeType=html&fmt=ahah

References

  1. Suntornsut P, Kasemsupat K, Silairatana S, Wongsuvan C, Jutrakul Y, Wuthiekanun V, Day NP, Peacock SJ, Limmathurotsakul D, 2013. Prevalence of melioidosis in patients with suspected pulmonary tuberculosis and sputum smear negative for acid-fast bacilli in northeast Thailand. Am J Trop Med Hyg 89: 382383.[Crossref]
    [Google Scholar]
  2. Rammaert B, Beauté J, Borand L, Hem S, Buchy P, Goyet S, Overtoom R, Angebault C, Te V, Try PL, Mayaud C, Vong S, Guillard B, 2011. Pulmonary melioidosis in Cambodia: a prospective study. BMC Infect Dis 11: 126.[Crossref]
    [Google Scholar]
  3. Conejero L, Patel N, de Reynal M, Oberdorf S, Prior J, Felgner PL, Titball RW, Salguero FJ, Bancroft GJ, 2011. Low-dose exposure of C57BL/6 mice to Burkholderia pseudomallei mimics chronic human melioidosis. Am J Pathol 179: 270280.[Crossref]
    [Google Scholar]
  4. Van Schaik E, Tom M, DeVinney R, Woods DE, 2008. Development of novel animal infection models for the study of acute and chronic Burkholderia pseudomallei pulmonary infections. Microbes Infect Inst Pasteur 10: 12911299.[Crossref]
    [Google Scholar]
  5. Van Schaik EJ, Tom M, Woods DE, 2009. Burkholderia pseudomallei isocitrate lyase is a persistence factor in pulmonary melioidosis: implications for the development of isocitrate lyase inhibitors as novel antimicrobials. Infect Immun 77: 42754283.[Crossref]
    [Google Scholar]
  6. Rammaert B, Goyet S, Tarantola A, Hem S, Rith S, Cheng S, Te V, Try PL, Guillard B, Vong S, Mayaud C, Buchy P, Borand L, 2013. Acute lower respiratory infections on lung sequelae in Cambodia, a neglected disease in highly tuberculosis-endemic country. Respir Med 107: 16251632.[Crossref]
    [Google Scholar]
  7. Dheda K, Booth H, Huggett JF, Johnson MA, Zumla A, Rook GA, 2005. Lung remodeling in pulmonary tuberculosis. J Infect Dis 192: 12011209.[Crossref]
    [Google Scholar]
  8. Vlieghe E, Kruy L, De Smet B, Kham C, Veng CH, Phe T, Koole O, Thai S, Lynen L, Jacobs J, 2011. Melioidosis, Phnom Penh, Cambodia. Emerg Infect Dis 17: 12891292.[Crossref]
    [Google Scholar]
  9. Wuthiekanun V, Suputtamongkol Y, Simpson AJ, Kanaphun P, White NJ, 2001. Value of throat swab in diagnosis of melioidosis. J Clin Microbiol 39: 38013802.[Crossref]
    [Google Scholar]
  10. Steingart KR, Sohn H, Schiller I, Kloda LA, Boehme CC, Pai M, Dendukuri N, 2013. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev 1: CD009593.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.13-0657a
Loading
  • Published online : 05 Feb 2014
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error